Adaptimmune Therapeutics PLC (ADAP)

0.6366 -0.03 (-4.23%) USD  |  NASDAQ  |  Nov 21, 16:00
0.622 -0.01 (-2.29%) After-Hours: 06:56
More

Adaptimmune Therapeutics EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for ADAP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to Free Cash Flow Data

View and export this data back to 2016. Upgrade now.
Date Value
November 21, 2024 --
November 20, 2024 --
November 19, 2024 --
November 18, 2024 --
November 15, 2024 --
November 14, 2024 --
November 13, 2024 --
November 12, 2024 --
November 11, 2024 --
November 08, 2024 --
November 07, 2024 --
November 06, 2024 --
November 05, 2024 --
November 04, 2024 --
November 01, 2024 --
October 31, 2024 --
October 30, 2024 --
October 29, 2024 --
October 28, 2024 --
October 25, 2024 --
October 24, 2024 --
October 23, 2024 --
October 22, 2024 --
October 21, 2024 --
October 18, 2024 --
Date Value
October 17, 2024 --
October 16, 2024 --
October 15, 2024 --
October 14, 2024 --
October 11, 2024 --
October 10, 2024 --
October 09, 2024 --
October 08, 2024 --
October 07, 2024 --
October 04, 2024 --
October 03, 2024 --
October 02, 2024 --
October 01, 2024 --
September 30, 2024 --
September 27, 2024 --
September 26, 2024 --
September 25, 2024 --
September 24, 2024 --
September 23, 2024 --
September 20, 2024 --
September 19, 2024 --
September 18, 2024 --
September 17, 2024 --
September 16, 2024 --
September 13, 2024 --

EV to Free Cash Flow Range, Past 5 Years

Upgrade
Minimum
Mar 15 2022
Upgrade
Maximum
Jan 03 2022
Upgrade
Average
Upgrade
Median
Aug 13 2024

EV to Free Cash Flow Benchmarks

Biodexa Pharmaceuticals PLC Upgrade
NuCana PLC Upgrade
Autolus Therapeutics PLC Upgrade
Bicycle Therapeutics PLC Upgrade
TC BioPharm (Holdings) PLC Upgrade

EV to Free Cash Flow Related Metrics

EV to CFO Upgrade
EV to Revenues Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade